Preview Mode Links will not work in preview mode

Apr 20, 2025

Featuring perspectives from Dr Jonathan Goldman and Dr Natasha B Leighl, including the following topics:

  • Introduction (0:00)
  • Current Management of Nonmetastatic and Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Prof Leighl (1:42)
  • Promising Novel Agents in Clinical Development; EGFR Exon 20 Mutation-Positive NSCLC — Dr Goldman (37:25)

CME information and select publications